These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 24066892)

  • 1. Immune senescence and vaccination in the elderly.
    Lang PO; Govind S; Bokum AT; Kenny N; Matas E; Pitts D; Aspinall R
    Curr Top Med Chem; 2013; 13(20):2541-50. PubMed ID: 24066892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunosenescence and herd immunity: with an ever-increasing aging population do we need to rethink vaccine schedules?
    Lang PO; Aspinall R
    Expert Rev Vaccines; 2012 Feb; 11(2):167-76. PubMed ID: 22309666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Problems and solutions to the development of vaccines in the elderly.
    Effros RB
    Immunol Allergy Clin North Am; 2003 Feb; 23(1):41-55. PubMed ID: 12645877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunosenescence and vaccine failure in the elderly: strategies for improving response.
    Boraschi D; Italiani P
    Immunol Lett; 2014 Nov; 162(1 Pt B):346-53. PubMed ID: 24960535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunosenescence: Implications for vaccination programmes in adults.
    Lang PO; Govind S; Michel JP; Aspinall R; Mitchell WA
    Maturitas; 2011 Apr; 68(4):322-30. PubMed ID: 21316879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccination in the elderly: what can be recommended?
    Lang PO; Aspinall R
    Drugs Aging; 2014 Aug; 31(8):581-99. PubMed ID: 24928553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Challenges in adult vaccination.
    de Gomensoro E; Del Giudice G; Doherty TM
    Ann Med; 2018 May; 50(3):181-192. PubMed ID: 29338438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunosenescence: Influenza vaccination and the elderly.
    Haq K; McElhaney JE
    Curr Opin Immunol; 2014 Aug; 29():38-42. PubMed ID: 24769424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biology of immune responses to vaccines in elderly persons.
    Weinberger B; Herndler-Brandstetter D; Schwanninger A; Weiskopf D; Grubeck-Loebenstein B
    Clin Infect Dis; 2008 Apr; 46(7):1078-84. PubMed ID: 18444828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccine responsiveness in the elderly: best practice for the clinic.
    Aspinall R; Lang PO
    Expert Rev Vaccines; 2014 Jul; 13(7):885-94. PubMed ID: 24890875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. OMIC Technologies and Vaccine Development: From the Identification of Vulnerable Individuals to the Formulation of Invulnerable Vaccines.
    Cotugno N; Ruggiero A; Santilli V; Manno EC; Rocca S; Zicari S; Amodio D; Colucci M; Rossi P; Levy O; Martinon-Torres F; Pollard AJ; Palma P
    J Immunol Res; 2019; 2019():8732191. PubMed ID: 31183393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccination and healthy aging.
    Maggi S
    Expert Rev Vaccines; 2010 Mar; 9(3 Suppl):3-6. PubMed ID: 20192710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Report on WHO meeting on immunization in older adults: Geneva, Switzerland, 22-23 March 2017.
    Teresa Aguado M; Barratt J; Beard JR; Blomberg BB; Chen WH; Hickling J; Hyde TB; Jit M; Jones R; Poland GA; Friede M; Ortiz JR
    Vaccine; 2018 Feb; 36(7):921-931. PubMed ID: 29336923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccination choices for older people, looking beyond age specific approaches.
    Aspinall R; Lang PO
    Expert Rev Vaccines; 2018 Jan; 17(1):23-30. PubMed ID: 29182479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The gracefully aging immune system.
    Boraschi D; Aguado MT; Dutel C; Goronzy J; Louis J; Grubeck-Loebenstein B; Rappuoli R; Del Giudice G
    Sci Transl Med; 2013 May; 5(185):185ps8. PubMed ID: 23677590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immunizing is not only a children's matter! : Why vaccinations are also important for adults].
    Kunze U; Groman E
    Wien Med Wochenschr; 2019 Jun; 169(9-10):203-214. PubMed ID: 28905246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Age-related changes in immunity: implications for vaccination in the elderly.
    Kovaiou RD; Herndler-Brandstetter D; Grubeck-Loebenstein B
    Expert Rev Mol Med; 2007 Feb; 9(3):1-17. PubMed ID: 17266794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccine effectiveness in older individuals: what has been learned from the influenza-vaccine experience.
    Lang PO; Govind S; Mitchell WA; Siegrist CA; Aspinall R
    Ageing Res Rev; 2011 Jul; 10(3):389-95. PubMed ID: 20888439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advocating vaccination of adults aged 60 years and older in Western Europe: statement by the Joint Vaccine Working Group of the European Union Geriatric Medicine Society and the International Association of Gerontology and Geriatrics-European Region.
    Michel JP; Chidiac C; Grubeck-Loebenstein B; Johnson RW; Lambert PH; Maggi S; Moulias R; Nicholson K; Werner H
    Rejuvenation Res; 2009 Apr; 12(2):127-35. PubMed ID: 19415978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Understanding immunosenescence and its impact on vaccination of older adults.
    Allen JC; Toapanta FR; Chen W; Tennant SM
    Vaccine; 2020 Dec; 38(52):8264-8272. PubMed ID: 33229108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.